Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 11.05M | $122.0M | 13.15% | -- | 2026-06-30 |
| BlackRock, Inc. | 8.96M | $99.0M | 10.67% | +2.72M | 2026-06-30 |
| RTW INVESTMENTS, LP | 7.41M | $82.0M | 8.83% | +54.7K | 2026-06-30 |
| Ridgeback Capital Investments L.P. | 7.31M | $80.0M | 8.71% | -- | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 4.55M | $50.0M | 5.42% | +2.27M | 2026-06-30 |
| STATE STREET CORP | 4.44M | $49.0M | 5.29% | +657.9K | 2026-06-30 |
| MONTANOVA CAPITAL, LLC | 4.39M | $48.0M | 5.23% | +168.0K | 2026-06-30 |
| Boxer Capital Management, LLC | 3.98M | $44.0M | 4.74% | +2.81M | 2026-06-30 |
| Caption Management, LLC | 3.96M | $43.0M | 4.71% | +2.53M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.90M | $32.0M | 3.45% | +136.9K | 2026-06-30 |
